Skip to main content
. Author manuscript; available in PMC: 2013 May 22.
Published in final edited form as: J Thorac Cardiovasc Surg. 2012 Dec 11;145(2):341–348. doi: 10.1016/j.jtcvs.2012.10.043

TABLE 1.

A. Baseline patient characteristics

Age (years) 72.9 ±10.9

Sex
  Male 58.7% (n=271)
  Female 41.3% (n= 191)

Race
  Caucasian 90.9% (n=420)
  African American 5.0% (n=23)
  Asian 0.6% (n=3)
  Hispanic 0.4% (n=2)
  Other/unspecified 3.0% (n=14)

Diabetes 29.4% (n=135)

Hypertension 81.4% (n=376)

Previous MI 19.5% (n=90)

Heart failure 84.0% (n=388)

NYHA class
  1 2.6% (n=12)
  2 34.0% (n=157)
  3 37.4% (n=173)
  4 10.0% (n=46)

Cerebrovascular disease 19.9% (n=92)

Peripheral arterial disease 16.4% (n=76)

Dialysis 5.0% (n=23)

Creatinine 1.11 ± 0.893

Ejection fraction (n=454) 56.4% ±12.8%

Mean aortic valve gradient (mmHg, n=434) 44.6 ±15.9

Mean pulmonary artery pressure(mmHg, n=290) 26.5 ± 9.873
B. Operative data

Nature of operation
  AVR 59.3% (n=274)
  AVR + CABG 27.5% (n=127)
  AVR + CABG +other 1.9% (n=9)
  AVR + other 8.0% (n=37)
  Aortic root replacement 1.7% (n=8)
  Aortic root replacement + other 1.5% (n=7)

Incidence
  First cardiac surgery operation 82.9% (n=383)
  First re-operation 15.6% (n=72)
  Second re-operation 1.3% (n=6)
  Third re-operation 0.2% (n=1)

Urgency
  Elective 71.9% (n=332)
  Urgent 26.4% (n=122)
  Emergent 1.7% (n=8)

Cardiopulmonary bypass time (min) 119 ± 49.6

Cross clamp time (min) 85.8 ± 39.1

Valve type
  Bioprosthesis 93.3% (n=432)
  Mechanical 6.1% (n=28)
  Homograft 0.4% (n=2)

Implant Size (mm) 23.7 ± 2.2

Abbreviations: MI, myocardial infarction; NYHA, New York Heart Association; mmHg, millimeters of mercury.

Abbreviations: AVR, aortic valve replacement; CABG, coronary artery bypass grafting; min, minutes; mm, millimeters.